Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Genelux (GNLX) Operating Expenses (2022 - 2025)

Genelux has reported Operating Expenses over the past 4 years, most recently at $9.4 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 3.36% year-over-year to $9.4 million; the TTM value through Dec 2025 reached $25.4 million, down 19.87%, while the annual FY2025 figure was $33.2 million, 4.79% up from the prior year.
  • Operating Expenses for Q4 2025 was $9.4 million at Genelux, up from $8.2 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $9.7 million in Q4 2024 and troughed at $3.2 million in Q4 2022.
  • A 4-year average of $6.9 million and a median of $6.9 million in 2024 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: soared 121.41% in 2023 and later dropped 3.36% in 2025.
  • Year by year, Operating Expenses stood at $3.2 million in 2022, then skyrocketed by 121.41% to $7.0 million in 2023, then skyrocketed by 39.24% to $9.7 million in 2024, then fell by 3.36% to $9.4 million in 2025.
  • Business Quant data shows Operating Expenses for GNLX at $9.4 million in Q4 2025, $8.2 million in Q3 2025, and $7.8 million in Q2 2025.